Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Market Cap	22.66B +166.9%
Revenue (ttm)	9.67B +15.3%
Net Income	1.41B +73.5%
EPS	8.42 +54.5%
Shares Out	168.76M
PE Ratio	15.94
Forward PE	20.85
Dividend	1.50 (1.12%)
Ex-Dividend Date	Apr 28, 2026

Volume	5,109,818
Open	134.30
Previous Close	134.30
Day's Range	127.27 - 141.90
52-Week Range	43.60 - 156.00
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company provides analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolics; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It exports its products. The company was incorporated in 1980 and is based in 10th of Ramadan City, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: PHAR

Financial Performance

In 2025, EGX:PHAR's revenue was 9.44 billion, an increase of 24.38% compared to the previous year's 7.59 billion. Earnings were 1.44 billion, an increase of 31.57%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 5, 2026

Data Sources Report a data error